McDonald's and other fast food restaurants are losing business because of GLP-1s including Ozempic. Now they're pivoting to ...

McDonald’s Corporation (NYSE:MCD) is updating its menu to match evolving customer preferences, with added emphasis on protein ...

As alcohol consumption declines, many have suggested that it is being driven by Gen Z reducing their intake for health ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it. Healthcare companies have been feverishly working on developing GLP-1 weight loss products in ...

The cost of GLP-1 medications varies widely, ranging from around $199 to over $1,500. Insurance coverage for GLP-1s is more common for diabetes management than for weight loss. Consumers can ...

During February’s national Heart Health Awareness Month, it’s important to note that GLP-1 drugs like Ozempic and Wegovy are surging at historic levels. Nearly 12% of U.S. adults now report using a ...

Researchers at Steno Diabetes Center Copenhagen reported that starting a GLP-1 receptor agonist (GLP-1RA) coincided with slightly healthier supermarket purchases. Grocery purchases from GLP-1RA users ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...

GLP-1 weight-loss drugs: What are they and how do they work? GLP-1 weight-loss drugs offer promising results but come with potential risks and unknown long-term effects, emphasizing the need for ...

GLP-1 drugs have gained worldwide attention for their ability to help some people lose weight, and new research shows they may be able to help with another common problem: Alcohol use. Patients who ...

LAS VEGAS -- GLP-1-based therapies may offer benefits in inflammatory bowel disease (IBD) that extend beyond their metabolic indication, according to two poster presentations at the Crohn's & Colitis ...